Does treatment with sodium-glucose co-transporter-2 inhibitors have an effect on sleep quality, quality of life, and anxiety levels in people with Type 2 diabetes mellitus?

BACKGROUND/AIM: To evaluate the impact of treatment with sodium-glucose co-transporter-2 (SGLT2) Inhibitors on quality of life (QoL), sleep quality (SQ), and anxiety levels in patients with Type 2 diabetes mellitus (T2DM). MATERIALS AND METHODS: Ninety-seven patients with type 2 diabetes admitted to...

Descripción completa

Detalles Bibliográficos
Autores principales: ŞAHİN, Serdar, HALİLOĞLU, Özlem, POLAT KORKMAZ, Özge, DURCAN, Emre, REKALI ŞAHİN, Hümeyra, YUMUK, Volkan Demirhan, DAMCI, Taner, İLKOVA, Hasan, OŞAR SİVA, Zeynep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Scientific and Technological Research Council of Turkey 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203126/
https://www.ncbi.nlm.nih.gov/pubmed/33356033
http://dx.doi.org/10.3906/sag-2008-37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203126/
https://www.ncbi.nlm.nih.gov/pubmed/33356033
http://dx.doi.org/10.3906/sag-2008-37

Ejemplares similares